Document
IPR2022-00853, No. 2021-65 Exhibit - Carl June Named One of Time���s 100 Most Influential People in the World, PENN MEDICINE Apr 26, 2018, httpspathologymedupennedunewscarl june nam...
Cite Document
IPR2022-00853, No. 2021-65 Exhibit - Carl June Named One of Time���s 100 Most Influential People in the World, PENN MEDICINE Apr 26, 2018, httpspathologymedupennedunewscarl june named one times 100 mo
+ More Snippets
Document
IPR2022-00853, No. 2027-71 Exhibit - Supplemental Information Disclosure Statement Initialed by Examiner June 17, 2016, US Patent Application No 14,996,953 (P.T.A.B. Jul. 19, 2022)
Cite Document
IPR2022-00853, No. 2027-71 Exhibit - Supplemental Information Disclosure Statement Initialed by Examiner June 17, 2016, US Patent Application No 14,996,953 (P.T.A.B. Jul. 19, 2022)
+ More Snippets
Document
IPR2022-00853, No. 2035-79 Exhibit - Grazyna Lipowska Bhalla, Targeted immunotherapy of cancer with CAR T cells achievements and challenges, 61 CANCER IMMUNOLOGY, IMMUNOTHER...
Cite Document
IPR2022-00853, No. 2035-79 Exhibit - Grazyna Lipowska Bhalla, Targeted immunotherapy of cancer with CAR T cells achievements and challenges, 61 CANCER IMMUNOLOGY, IMMUNOTHERAPY 953 2012 (P.T.A.B. Jul.
+ More Snippets
Document
IPR2022-00853, No. 2036-80 Exhibit - Latest paper from the father of CAR T CAR T really completely cured cancer, MEDICALTRENDORG, httpsmedicaltrendorg20220203latest paper from the fa...
Cite Document
IPR2022-00853, No. 2036-80 Exhibit - Latest paper from the father of CAR T CAR T really completely cured cancer, MEDICALTRENDORG, httpsmedicaltrendorg20220203latest paper from the father of car t car
+ More Snippets
Document
IPR2022-00853, No. 3001-91 Exhibit - Ex 3001 (P.T.A.B. Aug. 22, 2022)
Cite Document
IPR2022-00853, No. 3001-91 Exhibit - Ex 3001 (P.T.A.B. Aug. 22, 2022)
+ More Snippets
Document
IPR2022-00853, No. 1036-30 Exhibit - Boursier (P.T.A.B. Apr. 12, 2022)
Cite Document
IPR2022-00853, No. 1036-30 Exhibit - Boursier (P.T.A.B. Apr. 12, 2022)
+ More Snippets
Document
IPR2022-00853, No. 1029-23 Exhibit - Immunobiology (P.T.A.B. Apr. 12, 2022)
Cite Document
IPR2022-00853, No. 1029-23 Exhibit - Immunobiology (P.T.A.B. Apr. 12, 2022)
+ More Snippets
Document
IPR2022-00853, No. 1030-24 Exhibit - Molecular Biology (P.T.A.B. Apr. 12, 2022)
Cite Document
IPR2022-00853, No. 1030-24 Exhibit - Molecular Biology (P.T.A.B. Apr. 12, 2022)
+ More Snippets
Document
IPR2022-00853, No. 1028-22 Exhibit - US Patent Application No 15353,899 File History Excerpts (P.T.A.B. Apr. 12, 2022)
Cite Document
IPR2022-00853, No. 1028-22 Exhibit - US Patent Application No 15353,899 File History Excerpts (P.T.A.B. Apr. 12, 2022)
+ More Snippets
Document
IPR2022-00853, No. 1006-6 Exhibit - CART 19 ClinicalTrialsgov Internet Archive Decl and Exhibit (P.T.A.B. Apr. 12, 2022)
Cite Document
IPR2022-00853, No. 1006-6 Exhibit - CART 19 ClinicalTrialsgov Internet Archive Decl and Exhibit (P.T.A.B. Apr. 12, 2022)
+ More Snippets
Document
IPR2022-00853, No. 2011-55 Exhibit - Brian G Till et al, Adoptive immunotherapy for indolent non Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20 spec...
Cite Document
IPR2022-00853, No. 2011-55 Exhibit - Brian G Till et al, Adoptive immunotherapy for indolent non Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20 specific T cells,
+ More Snippets
Document
IPR2022-00853, No. 2008-52 Exhibit - FOOD AND DRUG ADMIN, BREAKTHROUGH THERAPY Jan 4, 2018, httpswwwfdagovpatientsfast track breakthrough therapy accelerated approval priorit...
Cite Document
IPR2022-00853, No. 2008-52 Exhibit - FOOD AND DRUG ADMIN, BREAKTHROUGH THERAPY Jan 4, 2018, httpswwwfdagovpatientsfast track breakthrough therapy accelerated approval priority reviewbreakthrough thera
+ More Snippets
Document
IPR2022-00853, No. 2041-85 Exhibit - Renier J Brentjens et al, Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts, 13 CLINICAL CANCER RSCH 5426 2...
Cite Document
IPR2022-00853, No. 2041-85 Exhibit - Renier J Brentjens et al, Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts, 13 CLINICAL CANCER RSCH 5426 2007 (P.T.A.B. Jul.
+ More Snippets
Document
IPR2022-00853, No. 2028-72 Exhibit - World Intell Prop Org Patent Application No WO 02077029 A2 (P.T.A.B. Jul. 19, 2022)
Cite Document
IPR2022-00853, No. 2028-72 Exhibit - World Intell Prop Org Patent Application No WO 02077029 A2 (P.T.A.B. Jul. 19, 2022)
+ More Snippets
Document
IPR2022-00853, No. 2004-48 Exhibit - Gina Kolata, A Cancer Treatment Makes Leukemia Vanish, but Creates More Mysteries, NY TIMES Feb 2, 2022, httpswwwnytimescom20220202healthleuk...
Cite Document
IPR2022-00853, No. 2004-48 Exhibit - Gina Kolata, A Cancer Treatment Makes Leukemia Vanish, but Creates More Mysteries, NY TIMES Feb 2, 2022, httpswwwnytimescom20220202healthleukemia car t immunothera
+ More Snippets